These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1665758)

  • 1. Bimane fluorogenic substrates for microdetermination of angiotensin converting enzyme level in serum.
    Sato E; Hattori H; Nishikawa S; Kanaoka Y
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2146-8. PubMed ID: 1665758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel fluorogenic substrates containing bimane system for microdetermination of angiotensin I converting enzyme.
    Sato E; Nishikawa S; Kanaoka Y
    Chem Pharm Bull (Tokyo); 1989 Jan; 37(1):145-7. PubMed ID: 2541935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel fluorogenic substrates for phosphodiesterase I.
    Sato E; Yoshikawa M; Kanaoka Y
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2287-9. PubMed ID: 2177681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorogenic bimane substrates with dabsyl group for endopeptidases; chymotrypsin, collagenase and thermolysin.
    Sato E; Hattori H; Kanaoka Y
    J Pharmacobiodyn; 1991 Oct; 14(10):599-604. PubMed ID: 1667927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New fluorogenic substrates containing bimane system for ribonuclease T1.
    Sato E; Itoh S; Kanaoka Y
    J Pharmacobiodyn; 1991 Jan; 14(1):43-6. PubMed ID: 1907323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internally quenched fluorogenic substrates for angiotensin I-converting enzyme.
    Araujo MC; Melo RI; Del Nery E; Alves MF; Juliano MA; Casarini DE; Juliano L; Carmona AK
    J Hypertens; 1999 May; 17(5):665-72. PubMed ID: 10403610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme in macro- and microvessels of the rat.
    Jandeleit K; Jackson B; Perich R; Paxton D; Johnston C
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):353-6. PubMed ID: 1648462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
    Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
    FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of bimane-peptide substrates to spectrofluorometric assays of metalloendopeptidases.
    Kajiwara K; Kumazaki T; Sato E; Kanaoka Y; Ishii S
    J Biochem; 1991 Sep; 110(3):345-9. PubMed ID: 1769960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimane fluorescent labels. Characterization of the bimane labeling of human hemoglobin.
    Kosower NS; Newton GL; Kosower EM; Ranney HM
    Biochim Biophys Acta; 1980 Apr; 622(2):201-9. PubMed ID: 7378449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fluorogenic substrate for angiotensin-converting enzyme in plasma.
    Russo FS; Persson AV; Wilson IB
    Clin Chem; 1978 Sep; 24(9):1539-42. PubMed ID: 210982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of angiotensin converting enzyme from different rat vascular beds.
    Jandeleit-Dahm K; Jackson B; Paxton D; Perich R; Johnston CI
    Blood Press; 1995 May; 4(3):170-6. PubMed ID: 7670651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition increases collateral-dependent muscle blood flow.
    Yang HT; Terjung RL
    J Appl Physiol (1985); 1993 Jul; 75(1):452-7. PubMed ID: 8397181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme.
    Araujo MC; Melo RL; Cesari MH; Juliano MA; Juliano L; Carmona AK
    Biochemistry; 2000 Jul; 39(29):8519-25. PubMed ID: 10913258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mg2+-dependent conformational changes and product release during DNA-catalyzed RNA ligation monitored by Bimane fluorescence.
    Turriani E; Höbartner C; Jovin TM
    Nucleic Acids Res; 2015 Jan; 43(1):40-50. PubMed ID: 25505142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorometric assay for angiotensin-converting enzyme activity.
    Kapiloff MS; Strittmatter SM; Fricker LD; Snyder SH
    Anal Biochem; 1984 Jul; 140(1):293-302. PubMed ID: 6091493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides.
    Cotton J; Hayashi MA; Cuniasse P; Vazeux G; Ianzer D; De Camargo AC; Dive V
    Biochemistry; 2002 May; 41(19):6065-71. PubMed ID: 11994001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intramolecularly quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin-I-converting enzyme and of bacterial dipeptidyl carboxypeptidase.
    Carmel A; Yaron A
    Eur J Biochem; 1978 Jun; 87(2):265-73. PubMed ID: 208842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of intramolecularly quenched fluorescent peptides as substrates of angiotensin-converting enzyme 2.
    Yan ZH; Ren KJ; Wang Y; Chen S; Brock TA; Rege AA
    Anal Biochem; 2003 Jan; 312(2):141-7. PubMed ID: 12531198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
    Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.